Home > Qtrly Results > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Quarterly Results Analysis [Sep2024]

SAMRAT PHARMACHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SAMRAT PHARMACHEM
Please provide your vote to see the results

SAMRAT PHARMACHEM Quarterly Results

Standalone Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹70 Cr ₹81 Cr ₹83 Cr ₹62 Cr ₹80 Cr ₹57 Cr ₹69 Cr ₹84 Cr
Expenses ₹67 Cr ₹78 Cr ₹81 Cr ₹62 Cr ₹80 Cr ₹57 Cr ₹70 Cr ₹81 Cr
Operating Income ₹3 Cr ₹3 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹3 Cr
Other Income ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹4 Cr ₹3 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹-1 Cr ₹3 Cr
Profit After Tax ₹3 Cr ₹2 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹-1 Cr ₹2 Cr
EPS ₹8.61 ₹6.68 ₹4.51 ₹1.11 ₹-0.61 ₹1.98 ₹-2.41 ₹6.78
Industry Peers & Returns1W1M1Y
SAMRAT PHARMACHEM -11.2% -18.4% -17.5%
SUN PHARMACEUTICAL INDUSTRIES -5.8% -3.2% 35.1%
CIPLA -3.9% -0.5% 13.9%
DR REDDYS LABORATORIES -1.2% 7.1% 17.8%
ZYDUS LIFESCIENCES -2.7% -0.1% 40.9%
DIVIS LABORATORIES -2.8% -3.6% 44.7%
MANKIND PHARMA -11.2% -2.3% 33.6%
TORRENT PHARMACEUTICALS -4.8% -2.7% 40.1%
LUPIN -8.6% 1.8% 56.9%

SAMRAT PHARMACHEM Quarterly Revenues

Revenues
Q-o-Q

-13.18 %

Y-o-Y

-12.00 %

Quarters Revenues % Change
Sep2024 ₹70 Cr
-13.18
Jun2024 ₹81 Cr
-2.25
Mar2024 ₹83 Cr
34.06
Dec2023 ₹62 Cr
-22.66
Sep2023 ₹80 Cr
38.74
Jun2023 ₹57 Cr
-16.91
Mar2023 ₹69 Cr
-17.49
Dec2022 ₹84 Cr -

SAMRAT PHARMACHEM Quarterly Operating Profit

Operating Profit
Q-o-Q

29.99 %

Y-o-Y

1,347.84 %

Quarters Operating Profit % Change
Sep2024 ₹3 Cr
29.99
Jun2024 ₹3 Cr
90.56
Mar2024 ₹1 Cr
1,100.00
Dec2023 ₹0 Cr
-51.29
Sep2023 ₹0 Cr
-69.91
Jun2023 ₹1 Cr
Positive
Mar2023 ₹0 Cr
Negative
Dec2022 ₹3 Cr -
Operating Margins
Q-o-Q

49.69 %

Y-o-Y

1,551.72 %

Quarters Operating Margin% % Change
Sep2024 4.79%
49.69
Jun2024 3.2%
95.12
Mar2024 1.64%
811.11
Dec2023 0.18%
-37.93
Sep2023 0.29%
-78.36
Jun2023 1.34%
Positive
Mar2023 -0.71%
Negative
Dec2022 3.91% -

SAMRAT PHARMACHEM Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

28.86 %

Y-o-Y

Positive

Quarters Profit After Tax % Change
Sep2024 ₹3 Cr
28.86
Jun2024 ₹2 Cr
48.03
Mar2024 ₹1 Cr
305.52
Dec2023 ₹0 Cr
Positive
Sep2023 ₹0 Cr
Negative
Jun2023 ₹1 Cr
Positive
Mar2023 ₹-1 Cr
Negative
Dec2022 ₹2 Cr -
PAT Margins
Q-o-Q

48.63 %

Y-o-Y

Positive

Quarters PAT Margin(%) % Change
Sep2024 3.79 %
48.63
Jun2024 2.55 %
50.89
Mar2024 1.69 %
201.79
Dec2023 0.56 %
Positive
Sep2023 -0.24 %
Negative
Jun2023 1.06 %
Positive
Mar2023 -1.08 %
Negative
Dec2022 2.5 % -

SAMRAT PHARMACHEM Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

28.89 %

Y-o-Y

Positive

Quarters EPS % Change
Sep2024 ₹8.61
28.89
Jun2024 ₹6.68
48.12
Mar2024 ₹4.51
306.31
Dec2023 ₹1.11
Positive
Sep2023 ₹-0.61
Negative
Jun2023 ₹1.98
Positive
Mar2023 ₹-2.41
Negative
Dec2022 ₹6.78 -

You may also like the below Video Courses